| Literature DB >> 15508112 |
Alain Fischer1, Salima Hacein-Bey-Abina, Marina Cavazzana-Calvo.
Abstract
Primary immunodeficiency diseases represent good targets for hematopoietic stem cell-targeted gene therapy. Severe combined immunodeficiencies (SCID) have been the first examples of successful gene therapy based on the ex vivo usage of retroviral vectors. New advances in the technology of gene transfer should further promote gene therapy as a safe and effective therapeutic strategy of immunodeficiency diseases.Entities:
Mesh：
Year: 2004 PMID： 15508112 DOI： 10.1053/j.seminhematol.2004.07.003
Source DB: PubMed Journal: Semin Hematol ISSN： 0037-1963 Impact factor: 3.851